203 related articles for article (PubMed ID: 6433796)
1. [Pharmacokinetics of intrathecal chemotherapy and clinical problems].
Fujimoto T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796
[TBL] [Abstract][Full Text] [Related]
2. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection.
Bleyer WA; Dedrick RL
Cancer Treat Rep; 1977 Jul; 61(4):703-8. PubMed ID: 577895
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.
Shapiro WR; Young DF; Mehta BM
N Engl J Med; 1975 Jul; 293(4):161-6. PubMed ID: 806016
[TBL] [Abstract][Full Text] [Related]
5. [Ventriculo-lumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal dissemination of malignant disease].
Nakagawa H; Fujita T; Kubo S; Izumoto S; Nakajima Y; Tsuruzono K
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1173-9. PubMed ID: 2053775
[TBL] [Abstract][Full Text] [Related]
6. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
Castagnola C; Nozza A; Corso A; Bernasconi C
Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal chemotherapy with antineoplastic agents in children.
Ruggiero A; Conter V; Milani M; Biagi E; Lazzareschi I; Sparano P; Riccardi R
Paediatr Drugs; 2001; 3(4):237-46. PubMed ID: 11354696
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic approaches to the treatment of meningeal malignancy.
Blaney SM; Balis FM; Poplack DG
Oncology (Williston Park); 1991 May; 5(5):107-16; discussion 123, 127. PubMed ID: 1831994
[TBL] [Abstract][Full Text] [Related]
9. High-dose methotrexate in acute lymphocytic leukemia.
Freeman AI; Wang JJ; Sinks LF
Cancer Treat Rep; 1977 Jul; 61(4):727-31. PubMed ID: 267510
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.
de Lemos ML; Monfared S; Denyssevych T; Hamata L; Jennings S; Thiessen B; Smith S; Waterhouse D
J Oncol Pharm Pract; 2009 Mar; 15(1):45-52. PubMed ID: 18772215
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non-Hodgkin's lymphoma.
Ettinger LJ; Chervinsky DS; Freeman AI; Creaven PJ
Cancer; 1982 Nov; 50(9):1676-82. PubMed ID: 6956429
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities.
Kwong YL; Yeung DY; Chan JC
Ann Hematol; 2009 Mar; 88(3):193-201. PubMed ID: 19050889
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of leukemic infiltrations of the central nervous system. Preliminary communication].
Swencz-Szczepanik K; Kołakowska-Polubiec K; Królikiewicz H; Kaczyńska D; Maj S; Pawelski S
Acta Haematol Pol; 1978; 9(4):257-61. PubMed ID: 282763
[TBL] [Abstract][Full Text] [Related]
15. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
Rebischung C; Hoffmann D; Stefani L; Desruet MD; Wang K; Adelstein SJ; Artignan X; Vincent F; Gauchez AS; Zhang H; Fagret D; Vuillez J; Kassis AI; Balosso J
Int J Radiat Biol; 2008 Dec; 84(12):1123-9. PubMed ID: 19061137
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans.
Strong JM; Collins JM; Lester C; Poplack DG
Cancer Res; 1986 Dec; 46(12 Pt 1):6101-4. PubMed ID: 3096555
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of patients with meningeal carcinomatosis.
Nakagawa H; Murasawa A; Kubo S; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
J Neurooncol; 1992 May; 13(1):81-9. PubMed ID: 1613540
[TBL] [Abstract][Full Text] [Related]
20. Cranial irradiation and permeability of blood-brain barrier to cytosine arabinoside in children with acute leukemia.
Riccardi R; Riccardi A; Lasorella A; Servidei T; Mastrangelo S
Clin Cancer Res; 1998 Jan; 4(1):69-73. PubMed ID: 9516954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
